We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Takeda and GammaDelta Therapeutics have formed a collaboration to develop GammaDelta Therapeutics' novel T cell platform, which is based on the unique properties of gamma delta (γδ) T cells derived from human tissues.